Published in Lab Business Week, October 26th, 2008
Mr. Moore will address the World Vaccine Congress on the funding challenges facing biotech financings on Monday, October 6th and will discuss the unique attributes of live Listeria vaccines for the treatment of cancer on Tuesday, October 7th.
He will also provide an update on the Phase 1 of Lovaxin C trial in recurrent cervical cancer, including the latest survival data. Mr. Moore will also discuss recent information on...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.